<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04456309</url>
  </required_header>
  <id_info>
    <org_study_id>LOCAL/2020/DR-02</org_study_id>
    <nct_id>NCT04456309</nct_id>
  </id_info>
  <brief_title>Brain MRI in Stroke Patients With Intracardiac Thrombus</brief_title>
  <acronym>BRAIN IRM</acronym>
  <official_title>Brain MRI Characteristics in Stroke Patients With Intracardiac Thrombus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute infarction patterns have been described in cardioembolic stroke, mainly with atrial&#xD;
      fibrillation (AF) or patent foramen ovale. We aimed to analyse acute infarction MRI&#xD;
      characteristics in stroke patients with intracardiac thrombus (ICT) compared with stroke&#xD;
      patients with AF.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2020</start_date>
  <completion_date type="Actual">November 15, 2020</completion_date>
  <primary_completion_date type="Actual">November 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Brain MRI characteristics</measure>
    <time_frame>Day of inclusion (Day 1)</time_frame>
    <description>infarction location (anterior/middle/posterior cerebral artery territory; anterior/posterior/mixed anterior-posterior circulation; multiterritorial infarction; brainstem; cerebellum; small cortical cerebellar infarctions [SCCI] or non-SCCI; cortical/subcortical/corticosubcortical)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Brain MRI characteristics</measure>
    <time_frame>Day of inclusion (Day 1)</time_frame>
    <description>lesion number</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Brain MRI characteristics</measure>
    <time_frame>Day of inclusion (Day 1)</time_frame>
    <description>subcortical lesion size (&gt;&lt;15 mm)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Brain MRI characteristics</measure>
    <time_frame>Day of inclusion (Day 1)</time_frame>
    <description>total infarction volume.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">122</enrollment>
  <condition>Stroke</condition>
  <condition>Intracardiac Thrombus</condition>
  <arm_group>
    <arm_group_label>Atrial fibrillation</arm_group_label>
    <description>stroke patients with atrial fibrillation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intracardiac thrombus</arm_group_label>
    <description>stroke patients with intracardiac thrombus</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention,</intervention_name>
    <description>pure observational study</description>
    <arm_group_label>Atrial fibrillation</arm_group_label>
    <arm_group_label>Intracardiac thrombus</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        2 groups of patients :&#xD;
&#xD;
        1 - Stroke patients with atrial fibrillation&#xD;
&#xD;
        2- Stroke patients with intracardiac thrombus&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  consecutive patients presenting with acute symptomatic cardioembolic infarction&#xD;
             associated with ICT, recruited and registered in the stroke database between June 2018&#xD;
             and November 2019 of our centre (Nîmes University Hospital, France). These patients&#xD;
             were compared with consecutive cardioembolic stroke patients with known or newly&#xD;
             discovered AF (in the absence of ICT on echocardiography), recruited during the same&#xD;
             time period.&#xD;
&#xD;
          -  Brain MRI (including diffusion-weighted imaging [DWI]) performed within one week of&#xD;
             symptom onset; complete etiological work-up including intracranial (time-of-flight&#xD;
             [TOF], gadolinium-enhanced magnetic resonance angiography [MRA], or computed&#xD;
             tomographic angiography [CTA]) and extracranial (gadolinium-enhanced MRA, CTA, or&#xD;
             duplex ultrasound) vessel imaging; transthoracic or transoesophageal echocardiography;&#xD;
             and ≥24h ECG monitoring (acute stroke unit monitoring and/or Holter ECG monitoring).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  opt-out patient&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dimitri RENARD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nīmes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Nîmes</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>June 22, 2020</study_first_submitted>
  <study_first_submitted_qc>June 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2020</study_first_posted>
  <last_update_submitted>November 18, 2020</last_update_submitted>
  <last_update_submitted_qc>November 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>brain MRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

